Chinese herbal extract may help kill off pancreatic cancer cells

July 1, 2014

A diagnosis of pancreatic cancer—the fourth most common cause of cancer death in the U.S.—can be devastating. Due in part to aggressive cell replication and tumor growth, pancreatic cancer progresses quickly and has a low five-year survival rate (less than 5 percent).

GRP78, a protein that protects cells from dying, is more abundant in and tissue than in normal organs and is thought to play a role in helping cells survive and thrive. Researchers at the University of Minnesota have found triptolide, an extract of the Chinese herb thunder god vine (Tirpterygium wilforii), suppresses GRP78, eventually leading to pancreatic cancer .

For mammals to use the proteins in our bodies, a process called protein folding must occur in the endoplasmic reticulum (ER) of cells. If proteins are not folded fast enough, unfolded proteins begin to build up and the cell becomes stressed. Prolonged ER stress activates a cellular process called the "unfolded protein response (UPR)". Initially, the UPR helps kick-start the cell's protein-folding ability, allowing it to function properly again. But if the problem doesn't resolve, the UPR triggers cell death.

GRP78 helps cells survive long enough for the UPR to kick in and correct protein-folding problems. However, GRP78 is available in higher quantities in pancreatic cancer cells, which assists the cancer cells in evading cell death, allowing them to live and multiply.

Triptolide has previously been shown to have a negative effect on pancreatic cancer cell viability and to block growth and spread of these cells. In this study led by Ashok Saluja, Ph.D., researchers observed the effects of triptolide on human pancreatic cancer cells and tissue. They found that the UPR worked properly in triptolide-treated cells to allow cell death in malfunctioning cells.

"Our study shows that although increased expression of GRP78 confers a survival advantage to the , prolonged exposure to triptolide induces chronic ER stress, which eventually leads to cell death," the authors stated. "In this context, inhibition of GRP78 by activation of the ER stress pathway by triptolide offers a novel mechanism for inhibiting the growth and survival of pancreatic cancer cells."

Explore further: Starving pancreatic cancer before it has a chance to feast

More information: The article "Triptolide activates unfolded protein response leading to chronic ER stress in pancreatic cancer cells" is published in the American Journal of Physiology—Gastrointestinal and Liver Physiology.

Related Stories

Starving pancreatic cancer before it has a chance to feast

June 23, 2014
(Medical Xpress)—Pancreatic cancer's low survival rate gives researchers from The University of Kansas Cancer Center even more reason to find a way to prevent and treat the hard-to-detect cancer. Drs. Snigdha Banerjee, ...

New drug to target and destroy tumor cells developed

October 18, 2012
A new drug created at the University of Minnesota may hold the answer to defeating pancreatic cancer, according to results published today in the prestigious journal Science Translational Medicine.

Novel drug cocktail may improve clinical treatment for pancreatic cancer

May 1, 2014
Pancreatic cancer is the fourth leading cause of cancer deaths in the U.S. and has the lowest overall survival rate of all major cancers (~6%). With current treatment options being met with limited success it is anticipated ...

Single protein promotes resistance to widely used anti-estrogen drugs

July 2, 2012
Researchers at Georgetown Lombardi Comprehensive Cancer Center have uncovered a single molecule they say is a major determinant of resistance to anti-estrogen therapy used to treat or prevent breast cancer in high-risk women.

Cancer cells co-opt immune response to escape destruction

December 18, 2012
Researchers at the University of California, San Diego School of Medicine report that tumor cells use stress signals to subvert responding immune cells, exploiting them to actually boost conditions beneficial to cancer growth.

Cell stress inflames the gut: New insights into chronic bowel inflammation

June 23, 2014
Inflammatory bowel disease (IBD) is a common condition in western industrialized countries. What triggers it, however, is not yet fully understood. Nutrition researchers at Technische Universität München (TUM) have now ...

Recommended for you

Major study of genetics of breast cancer provides clues to mechanisms behind the disease

October 23, 2017
Seventy-two new genetic variants that contribute to the risk of developing breast cancer have been identified by a major international collaboration involving hundreds of researchers worldwide.

Microbiologists contribute to possible new anti-TB treatment path

October 23, 2017
As part of the long effort to improve treatment of tuberculosis (TB), microbiologists led by Yasu Morita at the University of Massachusetts Amherst report that they have for the first time characterized a protein involved ...

New study shows how cells can be led down non-cancer path

October 23, 2017
As cells with a propensity for cancer break down food for energy, they reach a fork in the road: They can either continue energy production as healthy cells, or shift to the energy production profile of cancer cells. In a ...

Proton therapy lowers treatment side effects in pediatric head and neck cancer patients

October 23, 2017
Pediatric patients with head and neck cancer can be treated with proton beam therapy (PBT) instead of traditional photon radiation, and it will result in similar outcomes with less impact on quality of life. Researchers from ...

Big Data shows how cancer interacts with its surroundings

October 23, 2017
By combining data from sources that at first seemed to be incompatible, UC San Francisco researchers have identified a molecular signature in tissue adjacent to tumors in eight of the most common cancers that suggests they ...

Symptom burden may increase hospital length of stay, readmission risk in advanced cancer

October 23, 2017
Hospitalized patients with advanced cancer who report more intense and numerous physical and psychological symptoms appear to be at risk for longer hospital stays and unplanned hospital readmissions. The report from a Massachusetts ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

FMA
not rated yet Jul 03, 2014
I read some materials some time ago, the ingredient of triptolide in the extract of the Chinese herb thunder god vine is similar to another Chinese herb's ingredient "arteminsinin" from wormwood, the drug used to fight against malaria.

What "arteminsinin" has is an "endoperoxide bridge" (similar to what hydrogen peroxide has) in the molecule which will break when they contact with iron, when this bridge breaks some very aggressive intermediates will form, O2-, OH*...etc (similar to the Fenton's reaction when H2O2 contacts with iron), these intermediates will kill the cancer cells.

What triptolide has three endoperoxide bridges in the molecule, which implies it is three time more powerful than that of arteminsinin. However, it is more toxic when taken orally, If I remember correctly, thunder god vine can not be use orally.

The research of arteminsinin's fight against cancer was first done by Dr. Henry Lai from UW, anyone interested can search his info in google.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.